Confronta i metodi
Esamina i metodi selezionati fianco a fianco; le righe che differiscono sono evidenziate.
| Valutazione Funzionale della Terapia Oncologica-Mammella (FACT-B)× | Sistema di Valutazione dei Sintomi di Edmonton (ESAS)× | |
|---|---|---|
| Campo | Infermieristica oncologica | Infermieristica oncologica |
| Famiglia | Process / pipeline | Process / pipeline |
| Anno di origine≠ | 1997 | 1991 |
| Ideatore≠ | Marilyn Brady and David Cella | Eduardo Bruera |
| Tipo≠ | Patient self-report disease-specific QoL instrument | Patient self-report multisymptom palliative care scale |
| Fonte seminale≠ | Brady, M. J., Cella, D. F., Mo, F., et al. (1997). Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol, 15(3), 974–986. DOI ↗ | Bruera, E., Kuehn, N., Miller, M. J., Selmser, P., & Macmillan, K. (1991). The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care, 7(2), 6–9. DOI ↗ |
| Alias | FACT-B, FACT-Breast | ESAS, Edmonton Symptom Assessment Scale |
| Correlati | 4 | 4 |
| Sintesi≠ | The FACT-B is a comprehensive 36-item disease-specific quality-of-life instrument that integrates the generic FACT-G (27 items covering physical, social, emotional, and functional well-being) with a 9-item breast-cancer-specific subscale addressing body image, sexual function, arm symptoms, and treatment side effects. Developed by Brady et al. in 1997, the FACT-B is the gold-standard QoL measure for breast cancer research and clinical practice, used in hundreds of clinical trials and enabling comparison across breast cancer populations and treatment modalities. | The Edmonton Symptom Assessment System is a rapid, validated 9-item tool that assesses the severity of common symptoms in cancer and palliative care patients: pain, tiredness, nausea, depression, anxiety, drowsiness, appetite loss, general well-being, and shortness of breath. Developed by Bruera and colleagues at the University of Alberta in 1991, the ESAS has become the standard symptom-screening instrument in oncology clinics, palliative care units, and end-of-life care settings worldwide, enabling efficient symptom prioritization and management escalation. |
| ScholarGateInsieme di dati ↗ |
|
|